Clinical Significance:1. For auxiliary diagnosis, AML1/ETO gene fusion can be found in 92% of acute myeloid leukemia with partial differentiation type (AML-M2)
2. To assess the prognosis of patients with leukemia type M2, patients with positive fusion showed a better prognosis.
Storage and Stability:Store powder at 4°C liquid at -20°C. Store other components at 4°C. Stable for 6 months For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
